Presentation is loading. Please wait.

Presentation is loading. Please wait.

BAP1 deficiency results in thymic atrophy and loss of thymocyte populations. BAP1 deficiency results in thymic atrophy and loss of thymocyte populations.

Published byAdam Pavlík Modified over 5 years ago

Similar presentations

Presentation on theme: "BAP1 deficiency results in thymic atrophy and loss of thymocyte populations. BAP1 deficiency results in thymic atrophy and loss of thymocyte populations."— Presentation transcript:

1 BAP1 deficiency results in thymic atrophy and loss of thymocyte populations.
BAP1 deficiency results in thymic atrophy and loss of thymocyte populations. (A and B) Thymi (A) and hematoxylin and eosin staining of thymi (B) from Bap1fl/flRosa26CreERT2 and Bap1wt/wtRosa26CreERT2 mice 2.5 weeks after tamoxifen treatment. (C) Thymocyte numbers in Bap1fl/flRosa26CreERT2 and Bap1wt/wtRosa26CreERT2 mice 1 week after tamoxifen treatment (n = 6 to 7). (D) Cell numbers of the indicated thymocyte populations in Bap1fl/flRosa26CreERT2 and Bap1wt/wtRosa26CreERT2 mice 1 week after tamoxifen treatment, as determined by flow cytometry analysis. All data are representative of at least three independent experiments. For (C) and (D), each symbol represents an individual mouse and the line shows the median. *P < 0.05, **P < 0.01, ****P < based on unpaired Student’s t test. Teresita L. Arenzana et al. Sci. Immunol. 2018;3:eaal1953 Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works

Download ppt "BAP1 deficiency results in thymic atrophy and loss of thymocyte populations. BAP1 deficiency results in thymic atrophy and loss of thymocyte populations."

Similar presentations

Identification of combination treatment–responsive dysfunctional tumor-infiltrating CD8+ T cell population. Identification of combination treatment–responsive.

Identification of combination treatment–responsive dysfunctional tumor-infiltrating CD8+ T cell population. Identification of combination treatment–responsive.
Treg and Teff cell subsets show increased TCR overlap during colitis.

Treg and Teff cell subsets show increased TCR overlap during colitis.
Fibroblast activation in WT and NFATc2-deficient mice.

Fibroblast activation in WT and NFATc2-deficient mice.
MP cells are generated from naïve cells in the periphery.

MP cells are generated from naïve cells in the periphery.
The adjMFC end point is independent of baseline titers.

The adjMFC end point is independent of baseline titers.
Pathogenic potential of naïve Helicobacter-reactive CT6 cells in lymphopenic mice. Pathogenic potential of naïve Helicobacter-reactive CT6 cells in lymphopenic.

Pathogenic potential of naïve Helicobacter-reactive CT6 cells in lymphopenic mice. Pathogenic potential of naïve Helicobacter-reactive CT6 cells in lymphopenic.
LV envelope is responsible for DC activation.

LV envelope is responsible for DC activation.
Colonic Treg TCRs (CT2 and CT6) drive Teff cell development in inflammation. Colonic Treg TCRs (CT2 and CT6) drive Teff cell development in inflammation.

Colonic Treg TCRs (CT2 and CT6) drive Teff cell development in inflammation. Colonic Treg TCRs (CT2 and CT6) drive Teff cell development in inflammation.
LV DNA, genome, and capsid are not required for DC activation and CD8+ T cell priming in vivo. LV DNA, genome, and capsid are not required for DC activation.

LV DNA, genome, and capsid are not required for DC activation and CD8+ T cell priming in vivo. LV DNA, genome, and capsid are not required for DC activation.
FIP200 deficiency alters mitochondria activation and ROS production in T cells. FIP200 deficiency alters mitochondria activation and ROS production in.

FIP200 deficiency alters mitochondria activation and ROS production in T cells. FIP200 deficiency alters mitochondria activation and ROS production in.
VLPs activate DCs and antigen-specific CD8+ T cells via the STING and cGAS pathway. VLPs activate DCs and antigen-specific CD8+ T cells via the STING and.

VLPs activate DCs and antigen-specific CD8+ T cells via the STING and cGAS pathway. VLPs activate DCs and antigen-specific CD8+ T cells via the STING and.
CD8α+ DC-deficient mice are highly susceptible to Lm infection in the absence of CD169+ macrophages. CD8α+ DC-deficient mice are highly susceptible to.

CD8α+ DC-deficient mice are highly susceptible to Lm infection in the absence of CD169+ macrophages. CD8α+ DC-deficient mice are highly susceptible to.
NFATc2-deficient mice do not eliminate skin C. albicans infections.

NFATc2-deficient mice do not eliminate skin C. albicans infections.
Three different types of transfer functions with a codomain of [0,1].

Three different types of transfer functions with a codomain of [0,1].
TPAD training protocol.

TPAD training protocol.
Viral fusion is required for DC activation.

Viral fusion is required for DC activation.
LV activation of DCs and subsequent CD8+ T cell priming are dependent on STING and cGAS but not on MyD88, TRIF, or MAVS. LV activation of DCs and subsequent.

LV activation of DCs and subsequent CD8+ T cell priming are dependent on STING and cGAS but not on MyD88, TRIF, or MAVS. LV activation of DCs and subsequent.
Protein sequence alignment of the NS3 helicase–encoding region of 63 flaviviruses demonstrates conservation of a KIR2DS2-binding peptide. Protein sequence.

Protein sequence alignment of the NS3 helicase–encoding region of 63 flaviviruses demonstrates conservation of a KIR2DS2-binding peptide. Protein sequence.
Increased resistance of GPR55-deficient mice to indomethacin-induced intestinal permeability. Increased resistance of GPR55-deficient mice to indomethacin-induced.

Increased resistance of GPR55-deficient mice to indomethacin-induced intestinal permeability. Increased resistance of GPR55-deficient mice to indomethacin-induced.
Deficiency in myeloid-resident NRP1 affects systemic metabolism.

Deficiency in myeloid-resident NRP1 affects systemic metabolism.

Similar presentations

Ads by Google